Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05744739
Title Tomivosertib With Azacitide and Venetoclax for the Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Suitable for Intensive Chemotherapy
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Northwestern University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.